| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 144,169 | 146,307 | | Cost of Revenue | 32,972 | 69,210 | | | Gross Profit | 111,197 | 77,097 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 7,670 | 12,471 | | Non Recurring |
-
|
-
| | Others | 22,943 | 15,667 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 80,584 | 48,959 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 524 | (8) | | Earnings Before Interest And Taxes | 81,108 | 48,951 | | Interest Expense | 29,272 | 6,464 | | Income Before Tax | 51,836 | 42,487 | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 51,836 | 42,487 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 51,836 | 42,487 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $51,836 | $42,487 |
|
0.01% Nasdaq 
0.22%
Income Statement
